Acoltremon
1 NDC across 1 manufacturer|0 Generic,1 Brand
Acoltremon is used to treat dry eye syndromes, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on May 28, 2025.
Acoltremon is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $14.10 to $14.10 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$14.10 – $14.10
per EA
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing ACOLTREMON
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TRYPTYR 0.003% EYE DROP | $14.0955 per EA | — |
Frequently Asked Questions
What is Acoltremon used to treat?
Acoltremon is used to treat dry eye syndromes, per the National Library of Medicine's MED-RT classification.
How many Acoltremon products are on the market?
The Acoltremon drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Acoltremon?
NADAC reference prices for Acoltremon range from $14.0955 to $14.0955 per EA.
Which manufacturers make Acoltremon?
1 manufacturer lists Acoltremon in NADAC. Ranked by number of NDCs, the largest are Alcon Laboratories, Inc. (1).